LEPTIR

Leptir / Investors

Building a new category of neurotechnology.

Leptir Ltd is an early-stage United Kingdom company building a user-centred neurotechnology ecosystem. Conversations are welcome.

The position, in short.

Neurological experience is continuous. The tools built for it are episodic. Leptir is building for the continuous part.

The company. Leptir Ltd, established 13 May 2026 in the United Kingdom, founded by Dr Sandeep Kumar, MD, with Dr Arjuna Nagendran as advisor.

The platform. A user-centred ecosystem across five connected areas: sleep, headache and migraine, attention, sensory and motor symptoms, and cognition.

The first product. Akeso — headache intelligence built around the individual, currently in development.

The standard. EP3: Empowerment, Performance, Personalised, Privacy. It governs what gets built and what gets rejected.

The direction. Personalised, longitudinal, privacy-first, delivered through apps and wearable integration.

This page carries no funding, valuation, traction or market figures. Leptir publishes numbers only once they are real and verifiable.

Where the ecosystem goes.

Sequenced deliberately. Akeso first, because headache is where individual pattern-finding pays off fastest.

Now

  • Akeso — headache intelligence
  • EP3 product standard

Next

  • Sleep
  • Attention
  • Sensory and motor
  • Cognition

Future

  • Connected neurotechnology
  • Apps, wearables and personalised intelligence

For media and press.

Founder commentary, company background and brand assets are available on request.

Leptir uses only the storage needed to remember your theme and this choice. No analytics or advertising cookies are loaded. How Leptir uses cookies